Phosphorylation of the ␣-subunit of translation eukaryotic initiation factor-2 (eIF2) leads to the inhibition of protein synthesis in response to diverse conditions of stress. Serine͞threonine RNAdependent protein kinase (PKR) is an eIF2␣ kinase family member induced by type I IFN and activated in response to dsRNA or virus infection. Herein, we demonstrate that human PKR is a dual specificity kinase phosphorylated at Y101, Y162 and Y293 in vitro and in vivo. Site-specific tyrosine phosphorylation is essential for efficient dsRNA-binding, dimerization, kinase activation and eIF2␣ phosphorylation of PKR. Biologically, tyrosine phosphorylation of PKR mediates the antiviral and antiproliferative properties of the kinase through its ability to control translation. Our data demonstrate an important role of tyrosine phosphorylation in biochemical and biological processes caused or mediated by the activation of the eIF2␣ kinase PKR.
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cell proliferation ͉ protein phosphorylation ͉ translational control ͉ virus infection R egulation of gene expression at the translational level plays critical roles in cell proliferation and apoptosis (1) . Most of translational control is known to be exerted at the level of initiation (2) . An important mechanism of initiation proceeds through the regulation of eukaryotic initiation factor-2 (eIF2) activity, whose phosphorylation on S51 of its ␣-subunit results in the inhibition of protein synthesis (2) . Mammalian cells contain a family of eIF2␣ kinases and, among them, RNA-dependent protein kinase (PKR) is the most widely studied member (2) . PKR is a 68-kDa polypeptide in humans and a 65-kDa polypeptide in mice, and it binds dsRNA with high affinity (3) . The structural features of PKR include an N terminus dsRNAbinding domain and a C terminus kinase domain (KD) (3) . The dsRNA-binding domain contains two dsRNA-binding motifs (dsRBMs) that are located at amino acids 10-78 and 101-168 in human PKR (3) . The current model of PKR activation proposes latent PKR is in a folded ''locked'' conformation through an intermolecular interaction between the dsRBM II and KD (4, 5) . Binding of dsRNA to dsRBM I induces conformational changes that promote the cooperative binding of dsRBM II to dsRNA and expose the KD (4, 5) . These conformational alterations facilitate PKR dimerization through hydrophobic side-chain interactions between the regions at amino acids 244-296 of two kinase molecules, leading to autophosphorylation at multiple serine and threonine sites (3) (4) (5) . PKR expression is transcriptionally induced by type I IFN (i.e., IFN-␣͞␤) (6) , a property associated with the antiviral and antiproliferative actions of the kinase (7). Consistent with its antiviral property, ectopic expression of PKR in various mouse and human cell lines confers resistance to infection by a variety of viruses by eliciting a strong IFN response (7) . Activation of PKR leads to the inhibition of cell proliferation and destruction of cells by apoptosis (8) , whereas inhibition of PKR activity by dominant negative mutants facilitates malignant transformation and the induction of tumorigenesis (9) .
Although PKR has been characterized as a serine͞threonine kinase, two reports provided biochemical evidence for its possible regulation by tyrosine phosphorylation. First, Icely et al. (10) were able to clone mouse PKR using anti-phosphotyrosine Abs. Second, Lu et al. (11) demonstrated the tyrosine autophosphorylation of PKR in bacteria and budding yeast. Although these observations implied a dual specificity for PKR, they did not address the role of tyrosine phosphorylation in regulation of the kinase activity nor did they investigate the biological relevance of PKR tyrosine phosphorylation in cell proliferation, virus replication, and regulation of protein synthesis. Herein, we demonstrate that human PKR is a dual specificity kinase whose phosphorylation at Y101, Y162 and Y293 have profound effects on its biochemical and biological functions.
Results

First, we verified the tyrosine phosphorylation of PKR in vitro.
Active GST-PKR was treated with calf intestinal phosphatase (CIP) to remove preexisting autophosphorylated sites and then subjected to kinase reaction in the presence of [ 32 P-␥]ATP. Phosphoamino acid analysis of the 32 P-labeled kinase indicated the presence of phosphoserine, phosphothreonine, and phosphotyrosine residues (Fig. 1A) . To verify tyrosine phosphorylation, active GST-PKR was treated with a recombinant GST fusion protein consisting of human T cell tyrosine phosphatase (TC-PTP) (Fig. 1B) (12) . We found that treatment with the tyrosine phosphatase eliminated the tyrosine phosphorylation of GST-PKR WT (Fig. 1B , lane 1 of row a) as opposed to treatment with the catalytic mutant of the tyrosine phosphatase GST-TC-PTPD182A, which did not affect tyrosine autophosphorylation of the kinase (Fig. 1B, lane 3 of row a) . Also, detection of the kinase-defective GST-PKRK296R by anti-phosphotyrosine Abs was not possible (Fig. 1B , lanes 2 and 4 of row a), further suggesting that PKR protein does not contain an epitope that mimics tyrosine phosphorylation. Tyrosine-phosphorylated PKR was also detected in mammalian cells. That is, 2D gel electrophoresis and immunoblotting with an anti-phosphotyrosine Ab detected the tyrosine phosphorylation of PKR in human HT1080 cells (Fig. 1C , spots c-e of row a). In addition, the fractions of PKR recognized by the anti-phosphotyrosine Ab were shifted to more acidic areas of the gel, suggesting that the hyperphosphorylated forms of the kinase contained tyrosinephosphorylated protein. We also obtained evidence that tyrosine phosphorylation played a role in kinase activation. For example, treatment of GST-PKR WT with CIP, which targets phosphorylated serine, threonine, and tyrosine residues, resulted in a kinase that retained its capacity to be activated by autophosphorylation (Fig. 1D, lane 1 of row a) . However, the autophosphorylation capacity of the CIP-treated GST-PKR WT was significantly reduced by the presence of GST-TC-PTP (Fig. 1D , lane 2 of row a), thus indicating that tyrosine phosphorylation is required for optimal activation of the kinase.
When the sequences of mouse, human, and rat PKR proteins were compared, we noticed that several tyrosine residues were highly conserved between these species (data not shown). Among the conserved residues, Y293 attracted our attention because it lies within the catalytic subdomain II, which is involved in ATP binding (13) (Fig. 6A , which is published as supporting information on the PNAS web site). In addition, Y293 is located three residues upstream of the invariant K296, which is essential for the enzymatic activity of PKR (14) . We also focused on the N terminus of PKR and, specifically, on the conversed Y101 and Y162 within the dsRBM II of the human kinase (Fig. 6A) . This motif contains an ␣-␤-␤-␤-␣ fold with the two ␣-helices lying on each side and being packed against a three-stranded antiparallel ␤-sheet (Fig. 6B) (4) . A negative charge generated by phosphorylation at these tyrosines could cause an expulsion of the two ␣-helices and result in structural alterations that could possibly affect dsRNA binding and͞or kinase activity. To test whether the above tyrosine residues are phosphorylated, we generated Abs against phosphotyrosinecontaining peptides encompassing Y101 (pY101 phosphopeptide), Y162 (pY162 phosphopeptide), or Y293 (pY293 phosphopeptide) of human PKR. First, we examined the suitability of these Abs for detecting active PKR by immunoblotting (Fig. 2) . We noticed that the anti-PKRpY101 Ab recognized GST-PKR WT (Fig. 2 A, lane 1 of row a) but not the catalytically inactive GST-PKRK296R (Fig. 2 A, lane 2 of row a) . However, recognition of GST-PKR WT by anti-PKRpY101 Ab was lost when the pY101 phosphopeptide was present (Fig. 2 A, lane 3 of row a). Contrary to pY101 phosphopeptide, the presence of the nonphosphorylated Y101 peptide was not able to block the detection of active GST-PKR with the anti-PKRpY101 Ab ( Furthermore, immunodepletion of GST-PKR showed that Ϸ10% of the kinase is phosphorylated at each tyrosine residue in vitro (Fig.  7D ). We also found that human PKR was phosphorylated at all three tyrosine sites in HT1080 cells and that this site-specific phosphorylation was further induced after prolonged treatment with IFN-␣ in an attempt to enhance detection by up-regulating endogenous PKR (Fig. 3 ). These data demonstrated that Y101, Y162, and Y293 of PKR are phosphorylated both in vitro and in vivo.
We next investigated the functionality of tyrosine-phosphorylated PKR by examining the activity of PKR mutants bearing tyrosine-to-phenylalanine substitutions. Using GST fusion proteins, we found that the Y101F mutation partially diminished (Ϸ20%) the autophosphorylation levels of the kinase (Fig. 4A , lane 3 of row a), although eIF2␣ phosphorylation by GST-PKRY101F was as efficient as phosphorylation by GST-PKR WT (Fig. 4A, compare lanes 1 and 3 of row b) . In contrast, the Y162F or Y101F͞Y162F mutation(s) exhibited a higher inhibitory effect on PKR autophosphorylation (Ϸ60%) (Fig. 4A , lanes 4 and 5 of row a), which correlated with a significant reduction (Ϸ80%) in eIF2␣ phosphorylation by each GST-PKR mutant compared with GST-PKR WT (Fig. 4A , compare lane 1 with lanes 4 and 5 of row b). Interestingly, the Y293F mutation conveyed a strong inhibitory effect on PKR autophosphorylation (Fig. 4A , lane 3 of row d) and substrate phosphorylation (Fig.  4A , lane 3 of row e), indicating that Y293 is critical for kinase activity. Furthermore, the overall tyrosine phosphorylation of the GST-PKR tyrosine mutants was reduced. That is, we found that the Y101F and͞or Y162F mutation(s) diminished the tyrosine phosphorylation levels of GST-PKR by Ϸ50% compared with WT kinase (lanes 3-5 of row a in Fig. 8A , which is published as supporting information on the PNAS web site), whereas tyrosine phosphorylation of either GST-PKRY293F (Fig. 8A , lane 6 of row a) or the catalytic inactive GST-PKRK296R (Fig. 8A , lane 2 of row a) was barely detectable. Site-specific tyrosine phosphorylation of PKR also plays a role in kinase dimerization because GST-PKR tyrosine mutants were partially defective (Ϸ40%) in their interaction with PKR WT (Fig. 4B) . In line with the dimerization effects, dephosphorylation of GST-PKR WT with TC-PTP prevented its interaction with Flag-PKR WT (Fig. 8B ), further supporting a positive role of tyrosine phosphorylation in kinase dimerization. When the catalytic activities of Flag-PKR tyrosine mutants were tested in PKR Ϫ/Ϫ mouse embryonic fibroblasts (MEFs) (15), we found that autophosphor ylation of Flag-PKR Y101F or Flag-PKRY162F was diminished by Ϸ50% (Fig. 4C, lanes 4 and 5 of row a), whereas Flag-PKRY293F autophosphorylation was reduced to almost undetectable levels (Fig. 4C, lane 6 of row a) . We also noticed that the dsRNA-binding capacity of Flag-PKR tyrosine mutants was partially (Ϸ50%) defective compared with Flag-PKR WT (Fig. 4D) as was the dsRNA-binding activity of the catalytic inactive Flag-PKRK296R (Fig. 4D, compare lanes  3-6 with lane 2) . Collectively, these data suggested that sitespecific tyrosine phosphorylation is required for efficient dsRNA-binding, dimerization, and activation of PKR.
Next, we addressed the function of PKR tyrosine mutants in cell proliferation by performing colony formation assays in PKR Ϫ/Ϫ MEFs (Fig. 5A, row a) (15) . The colony formation efficiency with the vector DNA (control) was arbitrarily set to 100%. We observed that colony formation with the catalytic inactive Flag-PKRK296R or Flag-PKRY293F was almost 100%. However, cells expressing the Flag-PKRY101F or Flag-PKRY162F were less efficient in forming colonies (70-90%) than were control cells. Contrary to Flag-PKR mutants, colony formation with Flag-PKR WT was poor because of the strong antiproliferative effects of the WT kinase. Similar results were obtained in human HT1080 cells (data not shown), showing that control of cell proliferation by the PKR tyrosine mutants is not cell-type-or species-specific. Therefore, efficient tyrosine phosphorylation is necessary for the antiproliferative action of PKR.
We also examined the translational properties of the PKR tyrosine mutants. Translation was assessed by measuring ␤-galactosidase reporter gene activity in HT1080 cells cotransfected with each of the Flag-PKR mutants (Fig. 5B) (16) . We observed that PKR proteins bearing a Y101F, Y162F, or Y101F͞ Y162F mutation(s) had partial inhibitory effects on protein synthesis compared with Flag-PKR WT (Fig. 5B) . In contrast, Flag-PKRY293F exhibited the same ability to control the translation of the reporter gene as the catalytic inactive Flag-PKRK296R (Fig. 5B) . These data implied that tyrosine phosphorylation of PKR positively contributes to the inhibition of protein synthesis by the active kinase. Given the antiviral properties of PKR, we further investigated the function of PKR tyrosine mutants in cells infected with vesicular stomatitis virus (VSV). Specifically, we tested the ability of the PKR tyrosine mutants to modulate eIF2␣ phosphorylation in PKR Ϫ/Ϫ MEFs infected with VSV (Fig. 5C ). We noticed that eIF2␣ phosphorylation was more highly induced in VSV-infected cells expressing Flag-PKR WT (Fig. 5C , lane 8 of row b) than in control cells (Fig. 5C, lane 7 of row b) or cells expressing the PKR tyrosine mutants (Fig. 5C, lanes 9-11 of row b) . Similar to tyrosine mutants, induction of eIF2␣ phosphorylation was not possible in cells expressing the catalytic inactive Flag-PKR⌬6 (17) , which served as a negative control. To verify the antiviral function of PKR tyrosine phosphorylation, we performed plaque formation assays (18) to measure VSV production in HEK293 cells transiently expressing each of the Flag-PKR mutants (Fig. 5D) . We found that expression of Flag-PKR WT suppressed VSV replication by a factor of 10 4 to 10 plaque-forming units͞ml compared with cells transfected with vector DNA alone (Fig. 5D ). Contrary to Flag-PKR WT, each of the Flag-PKR tyrosine mutants, as well as the catalytically inactive Flag-PKRK296R, failed to suppress VSV replication. Virus replication was partially restored only in cells expressing Flag-PKRY101F at 24 h after infection. These findings revealed a role of PKR tyrosine phosphorylation in the inhibition of VSV replication.
Discussion
Herein, we demonstrate the dual specificity of PKR and identify three tyrosine residues whose phosphorylation controls the biochemical and biological properties of the kinase. Using phosphospecific Abs, we show the phosphorylation of PKR at Y101, Y162, and Y293 in vitro and in vivo. Immunodepletion experiments indicated that Ϸ10% of PKR is phosphorylated at each tyrosine residue in vitro (Fig. 7D) , although the stoichiometry of phosphorylation at each specific residue in vivo has not been determined. Y101 and Y162 flank the dsRBM II, which spans amino acids 101 and 167 in the human polypeptide (3) . Based on structural data of the N terminus dsRNA-binding region of PKR, we hypothesized that phosphorylation at Y101 and Y162 might be involved in dsRNA binding and consequently kinase activation. Consistent with this notion, functional characterization of Y101F and Y162F mutants revealed that phosphorylation at these sites is needed for efficient dsRNA binding and kinase dimerization and activation. Y293 is located within the kinase subdomain II of PKR and is conserved among the orthologs (Fig. 6A) and homologs of PKR (Fig. 9A , which is published as supporting information on the PNAS web site). The introduction of the Y293F mutation causes significant defects in PKR autophosphorylation and eIF2␣ phosphorylation, providing evidence for a critical function of this phosphorylated residue.
Analysis of the biological function showed that tyrosine phosphorylation is required for the antiproliferative and antiviral activities of PKR. Although both activities of the kinase have been shown to proceed through eIF2␣ phosphorylation, our findings provide evidence that tyrosine phosphorylation can modulate PKR function independently of eIF2␣ phosphoryla- tion. Specifically, the Y101F mutation impairs the translational, antiproliferative and antiviral activities of PKR without affecting the ability of the PKR mutant to phosphorylate eIF2␣. One possibility is that tyrosine phosphorylation functions as a switch for substrate specificity of PKR. Another possibility is that tyrosine phosphorylation is needed for the signaling properties of PKR through interactions with Src homology 2-containing proteins that could serve as substrates of the kinase. Consistent with this notion, it is of interest that the Src homology 2 containing protein Nck-1 controls mRNA translation through its functional and physical interactions with eIF2 (19, 20) .
Structural analysis of several kinases has shown that their folding properties are evolutionarily conserved (21, 22) . The proteins fold in two separate domains or lobes; the small N-terminal lobe is composed of a five-stranded ␤-sheet and one prominent ␣-helix, named helix ␣C, whereas the C-terminal lobe is larger and predominantly helical (21) . Recent studies on the 3D structure of KD of PKR showed that conformation of the P ϩ 1 loop in the kinase activation region adopts an extreme outward orientation from residues 448-452, approximating that of a tyrosine kinase (23) . Preceding and following this region, the activation segment of PKR returns to a canonical serine͞ threonine protein kinase conformation (23) . The unique distortion of P ϩ 1 loop may relate to the ability of PKR to phosphorylate on serine͞threonine residues and tyrosine residues, consistent with its function as a dual-specificity kinase. Most dual-specificity protein kinases employ a P ϩ 1 loop signature motif diagnostic of serine͞threonine-directed protein kinase activity and display the ability to phosphorylate serine͞ threonine residues and tyrosine residues (23) . This unique and more flexible structure endows PKR with a unique activation site that can accommodate tyrosine substrates and serine͞ threonine substrates (23) . Y293 lies within the VAIK motif, which contains K296, which coordinates ATP binding and is buried in the dimer interface of the two KDs (23) . Based on the structural data of KD only, the hydroxyl group of Y293 does not appear to be readily accessible for phosphorylation (23) . Moreover, the introduction of a bulky phosphate at Y293 is expected to impede KD dimerization. However, because the dsRNAbinding domain and the long ␤4-␤5 linger of PKR were omitted from the structural analysis, the remainder KD molecule may be disordered (24) . As such, the reported structural data may not fully represent the conformation of the KD in the full-length kinase (24) . Binding of dsRNA to PKR induces conformational changes (4, 5) , which may expose Y293 and make it more accessible for phosphorylation. A large number of known serine͞ threonine and tyrosine kinases contain a tyrosine residue located three residues upstream of the invariant lysine within the catalytic subdomain II (25) (Fig. 9A) . Introduction of the Y69F mutation in the catalytic subunit of the serine͞threonine protein kinase A did not affect its catalytic activity (Fig. 9B) , indicating that tyrosine-to-phenylalanine substitution in this position does not exhibit deleterious effects on other kinases and is unlikely to affect ATP binding.
The crystallographic studies of the KD of PKR also have led to a model that favors the trans-interdimer autophosphorylation of PKR in which dimers phosphorylate dimmers (26) . From these studies, autophosphorylation of PKR on T446 enhances its catalytic activity and is essential for specific recognition of eIF2␣. Our findings show that tyrosine phosphorylation is needed for optimal T446 phosphorylation (Fig. 8C) perhaps through structural alterations that facilitate trans-interdimer formation and͞or maintain the kinase in an active conformation. Such conformational changes have been shown to take place in the activation of other kinases, including the EphB2 receptor tyrosine kinase and the type I TGF␤ receptor (T␤R-I). Specifically, EphB2 receptor tyrosine kinase contains an N-terminal juxtamembrane region, which, in its unphosphorylated form, can act as a negative regulator (27) by stabilizing the N-terminal lobe of the kinase in an inactive conformation (28) . In contrast, the T␤R-I, a receptor serine͞threonine kinase, also contains an N-terminal regulatory segment, called the GS region, which, in its unphosphorylated form, can inhibit kinase activity when bound by the inhibitory protein FKBP12 (29) (30) (31) . When bound to FKBP12, the GS acquires a conformation that helps to maintain the N-terminal lobe of the kinase in a distorted inactive conformation (31) . These structural alterations of EphB2 and T␤R-I mediated by the N-terminal domains disrupt productive ATP bindings. For PKR, the three-dimensional structure of the whole kinase molecule has not as yet been resolved, and this adds more to the complexity of the interpretation of the role of tyrosine phosphorylation in the folding and conformational changes of the kinase.
The identification of PKR as a dual-specificity kinase is a finding with important implications in the diverse biological roles proposed for it. As tyrosine phosphorylation is involved in various cellular signal transduction pathways, it is tempting to speculate that the defects in signal transduction pathways and gene expression associated with human disease are due, at least in part, to modifications of PKR tyrosine kinase activity. It will be significant to identify tyrosine-phosphorylated substrates of PKR and provide a better insight for physiological role of the tyrosine kinase activity of PKR.
Materials and Methods
Generation of Anti-Phosphotyrosine 101, 162, and 293 Abs of Human PKR. Rabbit antiserum was produced against three chemically synthesized phosphopeptides GLSMGNpY 101 IGLINR, LAAKLApY 162 LQILSE, and RIDGKTpY 293 VIKRVK (where pY represents phosphotyrosine) of human PKR conjugated with keyhole limpet hemocyanin. Production of Abs in the serum from various bleeds was quantified by ELISA. Serum with the highest titer was pooled and purified by negative preadsorption against the nonphosphorylated form of each peptide. The final products were generated by affinity chromatography using the corresponding phosphorylated peptide at Y101, Y162, and Y293.
Immunoprecipitation and Immunoblot analysis. Immunoprecipitation and immunoblotting were performed as described in ref. 32 . The following Abs were used: anti-phosphotyrosine 4G10 mouse mAb (Upstate Biotechnology, Lake Placid, NY), antihemagglutinin 12CA5 mouse mAb (Roche), anti-human PKR mouse monoclonal F9 mAb (16), anti-GST rabbit polyclonal Ab (Amersham Pharmacia), anti-TC-PTP mouse mAb (33), antieIF2␣ rabbit polyclonal Ab (Cell Signaling Technology), antiphosphoS51 of eIF2␣ rabbit polyclonal Ab (16), anti-FLAG (M2) mouse mAb (Sigma), anti-phosphoT446 of human PKR (anti-PKRpT446) rabbit polyclonal Ab (Upstate Biotechnology), anti-phosphoY101 of human PKR (anti-PKRpY101) polyclonal Ab, anti-phosphoY162 of human PKR (anti-PKRpY162) polyclonal Ab, anti-phosphoY293 of human PKR (antiPKRpY293) polyclonal Ab, Ab against the catalytic D subunit of PKA (C-20; Santa Cruz Biotechnology). All Abs were used at a final concentration of 0.1-1 g͞ml. After incubation with horseradish peroxidase-conjugated anti-mouse or anti-rabbit IgG Abs (1:1,000 dilution, Amersham Pharmacia Biotech), proteins were visualized with the enhanced chemiluminescence detection system according to the manufacturer's instructions (ECL, Amersham Pharmacia Biotech). Quantification of the bands in the linear range of exposure was performed by densitometry using the National Institutes of Health IMAGE 1.54 software.
Further experimental details are listed in Supporting Materials and Methods, which is published as supporting information on the PNAS web site.
